|Slideshows|May 24, 2021

10 Critical Conversations to Evaluate the Status Quo in Psychiatry

Noteworthy arguments that challenge the state of affairs in psychiatry.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Psychiatrists Already Practice Comprehensive, Holistic Care—but More Resources Are Needed

ByJohn J. Miller, MD

May 8th 2026

Why Global Integration Is Essential for the Future of DSM

ByJohn J. Miller, MD

February 5th 2026

Is the DSM Helping or Hindering Patient Care? Rethinking Diagnosis, FDA Approval, and Access to Treatment

ByJohn J. Miller, MD

January 29th 2026

A Psychiatrist's Reflections on the Country

ByFrank A. Clark, MD

September 11th 2025

Robert Jay Lifton, MD: Lifting Us Up From Our Human Abyss

ByH. Steven Moffic, MD

September 5th 2025

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Register now!

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

10 Critical Conversations to Evaluate the Status Quo in Psychiatry

Related Content

Psychiatrists Already Practice Comprehensive, Holistic Care—but More Resources Are Needed

Why Global Integration Is Essential for the Future of DSM

Is the DSM Helping or Hindering Patient Care? Rethinking Diagnosis, FDA Approval, and Access to Treatment

A Psychiatrist's Reflections on the Country

Robert Jay Lifton, MD: Lifting Us Up From Our Human Abyss

Latest CME

Southern California Psychiatry Conference

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Monoamines: A Full House

Dose Lithium Once a Day at Night: An Update

Understanding the Complexities of Suicide Risk: A Conversation With Jill Harkavy-Friedman, PhD, and Elizabeth Ballard, PhD

Consensus on Overcoming Barriers to Long-Acting Injectable Use in Schizophrenia

Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD